We serve Chemical Name:3-(4-ethylphenyl)prop-2-enoic acid CAS:28784-98-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3-(4-ethylphenyl)prop-2-enoic acid
CAS.NO:28784-98-7
Synonyms:4-Ethylcinnamic acid;(E)-3-(4-ethylphenyl)-2-propenoic acid;p-Ethyl-zimtsaeure;2-Propenoic acid,3-(4-ethylphenyl)
Molecular Formula:C11H12O2
Molecular Weight:176.21200
HS Code:2916399090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:312.5ºC at 760 mmHg
Density:1.116g/cm3
Index of Refraction:1.589
PSA:37.30000
Exact Mass:176.08400
LogP:2.34680
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 4-Ethylcinnamic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Propenoic acid,3-(4-ethylphenyl) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-Ethylcinnamic acid Use and application,(E)-3-(4-ethylphenyl)-2-propenoic acid technical grade,usp/ep/jp grade.
Related News: New Zealand citizens and permanent residents and their immediate family members will still be able to enter — but must self-isolate for 14 days after arriving back into the country. 3-(4-ethylphenyl)prop-2-enoic acid manufacturer New Zealand citizens and permanent residents and their immediate family members will still be able to enter — but must self-isolate for 14 days after arriving back into the country. 3-(4-ethylphenyl)prop-2-enoic acid supplier The StartScore model was developed by the company��s in-house supply chain experts based on actual performance data. 3-(4-ethylphenyl)prop-2-enoic acid vendor Onconova Therapeutics, Inc. and Inceptua Medicines Access (a business unit of the Inceptua Group) recently announced they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world. 3-(4-ethylphenyl)prop-2-enoic acid factory Our collaboration with Mankind demonstrates our commitment towards providing novel, innovative treatment options for efficient diabetes management, Glenmark Pharmaceuticals President, India Formulations, Middle East and Africa Sujesh Vasudevan said.
